Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8152 | 1286 | 34.1 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
8152 | 1 | BURNS TRAUMA CRIT CARE//MEROPENEM//AUGMENTED RENAL CLEARANCE | 1286 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BURNS TRAUMA CRIT CARE | address | 1152656 | 11% | 33% | 146 |
2 | MEROPENEM | authKW | 405586 | 7% | 19% | 90 |
3 | AUGMENTED RENAL CLEARANCE | authKW | 343079 | 1% | 85% | 17 |
4 | ANTIINFECT DEV | address | 315362 | 5% | 23% | 59 |
5 | PIPERACILLIN | authKW | 313096 | 4% | 25% | 52 |
6 | EXTENDED INFUSION | authKW | 290846 | 1% | 88% | 14 |
7 | CLIN PHARMACOTHER Y | address | 260554 | 2% | 37% | 30 |
8 | TAZOBACTAM | authKW | 257341 | 3% | 31% | 35 |
9 | CONTINUOUS INFUSION | authKW | 238299 | 6% | 14% | 71 |
10 | PROLONGED INFUSION | authKW | 220965 | 2% | 42% | 22 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 12952 | 58% | 0% | 746 |
2 | Infectious Diseases | 10787 | 28% | 0% | 354 |
3 | Microbiology | 8241 | 34% | 0% | 435 |
4 | Critical Care Medicine | 4520 | 12% | 0% | 152 |
5 | Urology & Nephrology | 372 | 6% | 0% | 73 |
6 | Transplantation | 130 | 2% | 0% | 32 |
7 | Anesthesiology | 121 | 2% | 0% | 28 |
8 | Medical Laboratory Technology | 88 | 2% | 0% | 21 |
9 | Toxicology | 18 | 2% | 0% | 25 |
10 | Biochemical Research Methods | 18 | 2% | 0% | 29 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BURNS TRAUMA CRIT CARE | 1152656 | 11% | 33% | 146 |
2 | ANTIINFECT DEV | 315362 | 5% | 23% | 59 |
3 | CLIN PHARMACOTHER Y | 260554 | 2% | 37% | 30 |
4 | ANTI INFECT DEV | 119158 | 1% | 31% | 16 |
5 | BASIL HETZEL TRANSLAT HLTH | 87649 | 1% | 31% | 12 |
6 | PHARMACOCINET TOXICOL CLIN | 60775 | 1% | 20% | 13 |
7 | HYPERBAR INTENS CARE MED | 53420 | 0% | 75% | 3 |
8 | EPE PRACETA PROF MOTA PINTO | 47486 | 0% | 100% | 2 |
9 | PRINCETON CORP | 47486 | 0% | 100% | 2 |
10 | INTENS CARE MED | 45627 | 7% | 2% | 85 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 46961 | 7% | 2% | 87 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 25997 | 13% | 1% | 161 |
3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 17831 | 8% | 1% | 97 |
4 | PHARMACOTHERAPY | 10076 | 3% | 1% | 44 |
5 | JOURNAL OF INFECTION AND CHEMOTHERAPY | 9225 | 2% | 2% | 21 |
6 | ANNALS OF PHARMACOTHERAPY | 3931 | 2% | 1% | 30 |
7 | INTENSIVE CARE MEDICINE | 3682 | 2% | 1% | 31 |
8 | CLINICAL PHARMACOKINETICS | 3610 | 1% | 1% | 19 |
9 | CLINICAL THERAPEUTICS | 2956 | 2% | 1% | 25 |
10 | CRITICAL CARE | 2951 | 2% | 1% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEROPENEM | 405586 | 7% | 19% | 90 | Search MEROPENEM | Search MEROPENEM |
2 | AUGMENTED RENAL CLEARANCE | 343079 | 1% | 85% | 17 | Search AUGMENTED+RENAL+CLEARANCE | Search AUGMENTED+RENAL+CLEARANCE |
3 | PIPERACILLIN | 313096 | 4% | 25% | 52 | Search PIPERACILLIN | Search PIPERACILLIN |
4 | EXTENDED INFUSION | 290846 | 1% | 88% | 14 | Search EXTENDED+INFUSION | Search EXTENDED+INFUSION |
5 | TAZOBACTAM | 257341 | 3% | 31% | 35 | Search TAZOBACTAM | Search TAZOBACTAM |
6 | CONTINUOUS INFUSION | 238299 | 6% | 14% | 71 | Search CONTINUOUS+INFUSION | Search CONTINUOUS+INFUSION |
7 | PROLONGED INFUSION | 220965 | 2% | 42% | 22 | Search PROLONGED+INFUSION | Search PROLONGED+INFUSION |
8 | PHARMACODYNAMICS | 204186 | 16% | 4% | 201 | Search PHARMACODYNAMICS | Search PHARMACODYNAMICS |
9 | PIPERACILLIN TAZOBACTAM | 157740 | 3% | 18% | 36 | Search PIPERACILLIN+TAZOBACTAM | Search PIPERACILLIN+TAZOBACTAM |
10 | PROBABILITY OF TARGET ATTAINMENT | 105758 | 1% | 64% | 7 | Search PROBABILITY+OF+TARGET+ATTAINMENT | Search PROBABILITY+OF+TARGET+ATTAINMENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GRUPPER, M , KUTI, JL , NICOLAU, DP , (2016) CONTINUOUS AND PROLONGED INTRAVENOUS BETA-LACTAM DOSING: IMPLICATIONS FOR THE CLINICAL LABORATORY.CLINICAL MICROBIOLOGY REVIEWS. VOL. 29. ISSUE 4. P. 759 -772 | 91 | 81% | 0 |
2 | SIME, FB , ROBERTS, MS , PEAKE, SL , LIPMAN, J , ROBERTS, JA , (2012) DOES BETA-LACTAM PHARMACOKINETIC VARIABILITY IN CRITICALLY ILL PATIENTS JUSTIFY THERAPEUTIC DRUG MONITORING? A SYSTEMATIC REVIEW.ANNALS OF INTENSIVE CARE. VOL. 2. ISSUE . P. - | 83 | 77% | 33 |
3 | SINNOLLAREDDY, MG , ROBERTS, MS , LIPMAN, J , ROBERTS, JA , (2012) BETA-LACTAM PHARMACOKINETICS AND PHARMACODYNAMICS IN CRITICALLY ILL PATIENTS AND STRATEGIES FOR DOSE OPTIMIZATION: A STRUCTURED REVIEW.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 39. ISSUE 6. P. 489 -496 | 71 | 77% | 13 |
4 | UDY, AA , ROBERTS, JA , LIPMAN, J , (2013) CLINICAL IMPLICATIONS OF ANTIBIOTIC PHARMACOKINETIC PRINCIPLES IN THE CRITICALLY ILL.INTENSIVE CARE MEDICINE. VOL. 39. ISSUE 12. P. 2070-2082 | 71 | 61% | 40 |
5 | OSTHOFF, M , SIEGEMUND, M , BALESTRA, G , ABDUL-AZIZ, MH , ROBERTS, JA , (2016) PROLONGED ADMINISTRATION OF BETA-LACTAM ANTIBIOTICS - A COMPREHENSIVE REVIEW AND CRITICAL APPRAISAL.SWISS MEDICAL WEEKLY. VOL. 146. ISSUE . P. - | 60 | 80% | 0 |
6 | CHOI, G , GOMERSALL, CD , TIAN, Q , JOYNT, GM , FREEBAIRN, R , LIPMAN, J , (2009) PRINCIPLES OF ANTIBACTERIAL DOSING IN CONTINUOUS RENAL REPLACEMENT THERAPY.CRITICAL CARE MEDICINE. VOL. 37. ISSUE 7. P. 2268 -2282 | 69 | 66% | 62 |
7 | ROBERTS, JA , ABDUL-AZIZ, MH , LIPMAN, J , MOUTON, JW , VINKS, AA , FELTON, TW , HOPE, WW , FARKAS, A , NEELY, MN , SCHENTAG, JJ , ET AL (2014) INDIVIDUALISED ANTIBIOTIC DOSING FOR PATIENTS WHO ARE CRITICALLY ILL: CHALLENGES AND POTENTIAL SOLUTIONS.LANCET INFECTIOUS DISEASES. VOL. 14. ISSUE 6. P. 498-509 | 65 | 47% | 63 |
8 | ABDUL-AZIZ, MH , DULHUNTY, JM , BELLOMO, R , LIPMAN, J , ROBERTS, JA , (2012) CONTINUOUS BETA-LACTAM INFUSION IN CRITICALLY ILL PATIENTS: THE CLINICAL EVIDENCE.ANNALS OF INTENSIVE CARE. VOL. 2. ISSUE . P. - | 64 | 68% | 20 |
9 | ABDUL-AZIZ, MH , LIPMAN, J , AKOVA, M , BASSETTI, M , DE WAELE, JJ , DIMOPOULOS, G , DULHUNTY, J , KAUKONEN, KM , KOULENTI, D , MARTIN, C , ET AL (2016) IS PROLONGED INFUSION OF PIPERACILLIN/TAZOBACTAM AND MEROPENEM IN CRITICALLY ILL PATIENTS ASSOCIATED WITH IMPROVED PHARMACOKINETIC/PHARMACODYNAMIC AND PATIENT OUTCOMES? AN OBSERVATION FROM THE DEFINING ANTIBIOTIC LEVELS IN INTENSIVE CARE UNIT PATIENTS (DALI) COHORT.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 71. ISSUE 1. P. 196 -207 | 40 | 87% | 3 |
10 | GONCALVES-PEREIRA, J , POVOA, P , (2011) ANTIBIOTICS IN CRITICALLY ILL PATIENTS: A SYSTEMATIC REVIEW OF THE PHARMACOKINETICS OF BETA-LACTAMS.CRITICAL CARE. VOL. 15. ISSUE 5. P. - | 56 | 65% | 87 |
Classes with closest relation at Level 1 |